Journal of Ophthalmology / 2016 / Article / Tab 2

Clinical Study

Long-Term Observation of Triplex Surgery for Cataract after Phakic 6H Implantation for Super High Myopia

Table 2

Clinical data before and after triplex surgery.

Case/eye⁢Follow-up period (m) ⁢Pupil diameter (mm)⁢LOCS III classification⁢PhacoemulsificationBCVA (logMAR)⁢SE after the triplex surgeryECD (cells/mm2)IOL
PowerTimePrePostAt last follow-upPrePost (1 m) At last follow-upPowerModel

1/R54N3C1P112.0180.400.401.00−2.25188917506814.0Rayner
1/L54N4C2P112.5210.600.601.00−0.75149511535723.0Rayner
2/R63N3C1P111.3100.601.301.00−2.251832176510156.0HumanOpt
2/L57N1C1P11.011.001.303.00−3.751676129812244.0HumanOpt
3/R36N3C1P19.0130.520.100.10−1.502122207219875.0Rayner
3/L36N2C1P12.020.701.001.00−0.75131412159802.0Rayner
4/R36N3C1P110.0170.400.000.00−1.752077210520114.0HumanOpt
4/L26N3C2P112.5210.520.000.00−2.752228220520336.0HumanOpt
5/L38N3C1P19.9150.300.000.00−2.50142213991348−2.0HumanOpt
6/R24N3C1P116.6120.520.220.15−0.50186918431889−1.0HumanOpt
6/L51N3C1P112.5130.520.220.22−1.75202820231988−2.0HumanOpt
7/R67N4C2P121.0301.401.000.82−0.50223822492591−5.0MA60MA
8/R54N2C1P111.590.700.300.30−1.75227423242363−3.5MA60MA
8/L55N3C1P117.0200.520.220.30−1.50241923422465−3.0MA60MA
9/L59N2C1P18.0111.300.700.60−1.25325531812813−6.0HumanOpt
10/L29N3C1P113.0140.600.150.15−0.251660155916472.0HumanOpt
Mean (SD) 46 (14)11.1 (6.5)15.8 (9.2)0.66 (0.31)0.47 (0.46)0.60 (0.75)−1.61 (0.95)1987 (468)1905 (524)1725 (688)0.8 (4.0)

m: month(s); BCVA: best corrected visual acuity; Pre: before the triplex surgery; Post: after the triplex surgery; ECD: endothelial cell density; SE: spherical equivalent.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.